Franco, Reenizz .
HRN: 19-39-73 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/29/2022
CEFUROXIME 750MG (VIAL)
07/29/2022
08/05/2022
IV
225 Mg
Q8hrs
AGE With Mild Dehydration; PCAP B
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes